Gastrointestinal Cancer News

WASHINGTON — In this exclusive video, Seth D. Crockett, MD, MPH, of University of North Carolina at Chapel Hill, highlights four key take-aways in colorectal cancer screening and prevention at Digestive Disease Week.

CHICAGO — The addition of docetaxel to S-1 after resection extended RFS for patients with stage III gastric, according to results of a phase 3 study conducted in Japan and presented at ASCO Annual Meeting.

CHICAGO — High-dose proton pump inhibitors in combination with low-dose aspirin may prevent the development of esophageal cancer among patients with Barrett’s esophagus, according to findings from the AspECT trial presented at the ASCO Annual Meeting.

CHICAGO — Adjuvant FOLFIRINOX chemotherapy improved OS and PFS compared with gemcitabine among patients with surgically removed nonmetastatic pancreatic ductal adenocarcinoma, according to data from the phase 3 PRODIGE 24/CCTG PA.6 trial presented at ASCO Annual Meeting.

CHICAGO — The addition of hyperthermic intraperitoneal chemotherapy to surgical resection did not provide a survival benefit for patients with metastatic peritoneal colorectal cancer, according to results of the phase 3 PRODIGE 7 trial presented at ASCO Annual Meeting.

CHICAGO — JTX-2011 monotherapy or in combination with nivolumab appeared well-tolerated and induced antitumor responses among patients previously treated for gastric cancer and triple-negative breast cancer, according to results presented at ASCO Annual Meeting.

CHICAGO — The use of next-generation sequencing on tumors to match therapy to genetic changes within tumors slowed cancer growth and prolonged survival among patients with various cancers, according to results from a retrospective analysis of the IMPACT clinical trial presented at ASCO Annual Meeting.

CHICAGO — Microsatellite instability-high tumors predicted occurrence of Lynch syndrome across various cancer types, not just cancers commonly known to be associated with the disease, according to study results presented at ASCO Annual Meeting.

CHICAGO — Use of geriatric assessment during routine care of older individuals with advanced cancer significantly improved physician-patient communication about age-related concerns, according to randomized study results presented at ASCO Annual Meeting.

CHICAGO — Colorectal cancer treatment for patients who lived in western Washington State cost more than twice as much as treatment for individuals with the same malignancy who lived in a demographically similar region in Canada, according to study results presented at ASCO Annual Meeting.